Medical Properties Trust (NYSE:MPW) was downgraded by equities research analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating in a research note issued to investors on Friday, January 5th, MarketBeat Ratings reports. They presently have a $13.00 price objective on the real estate investment trust’s stock, down from their prior price objective of $15.00. Robert W. Baird’s price objective indicates a potential downside of 1.07% from the company’s current price.
Other equities research analysts have also issued research reports about the stock. Zacks Investment Research raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $15.00 target price for the company in a report on Tuesday, October 24th. ValuEngine raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. SunTrust Banks reissued a “buy” rating and issued a $15.00 price objective on shares of Medical Properties Trust in a report on Friday, November 3rd. KeyCorp reissued a “hold” rating on shares of Medical Properties Trust in a report on Sunday, September 17th. Finally, JPMorgan Chase & Co. raised shares of Medical Properties Trust from an “underweight” rating to a “neutral” rating and set a $14.50 price objective for the company in a report on Friday, December 15th. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Medical Properties Trust has a consensus rating of “Hold” and an average price target of $14.30.
Medical Properties Trust (MPW) traded down $0.16 during trading on Friday, hitting $13.14. 1,550,000 shares of the stock were exchanged, compared to its average volume of 2,120,000. Medical Properties Trust has a fifty-two week low of $11.90 and a fifty-two week high of $14.22. The stock has a market capitalization of $4,790.00, a price-to-earnings ratio of 17.29, a price-to-earnings-growth ratio of 1.63 and a beta of 0.96. The company has a debt-to-equity ratio of 1.26, a current ratio of 2.55 and a quick ratio of 2.55.
Medical Properties Trust (NYSE:MPW) last released its earnings results on Thursday, November 2nd. The real estate investment trust reported $0.33 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.32 by $0.01. Medical Properties Trust had a net margin of 39.95% and a return on equity of 7.36%. The business had revenue of $176.60 million during the quarter, compared to analyst estimates of $172.57 million. During the same quarter in the prior year, the firm earned $0.30 earnings per share. The company’s revenue for the quarter was up 39.5% compared to the same quarter last year. equities analysts expect that Medical Properties Trust will post 1.33 EPS for the current fiscal year.
A number of hedge funds and other institutional investors have recently bought and sold shares of MPW. Vanguard Group Inc. lifted its position in Medical Properties Trust by 6.6% in the second quarter. Vanguard Group Inc. now owns 57,790,855 shares of the real estate investment trust’s stock valued at $743,768,000 after buying an additional 3,561,518 shares during the last quarter. Systematic Financial Management LP acquired a new position in Medical Properties Trust in the second quarter valued at about $29,018,000. Bank of New York Mellon Corp lifted its position in Medical Properties Trust by 9.5% in the third quarter. Bank of New York Mellon Corp now owns 14,803,927 shares of the real estate investment trust’s stock valued at $194,375,000 after buying an additional 1,278,480 shares during the last quarter. Prudential Financial Inc. lifted its position in Medical Properties Trust by 28.7% in the third quarter. Prudential Financial Inc. now owns 5,562,595 shares of the real estate investment trust’s stock valued at $73,037,000 after buying an additional 1,241,797 shares during the last quarter. Finally, Balyasny Asset Management LLC acquired a new position in Medical Properties Trust in the second quarter valued at about $15,711,000. 81.27% of the stock is currently owned by institutional investors.
WARNING: This news story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another site, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/01/28/medical-properties-trust-mpw-lowered-to-neutral-at-robert-w-baird.html.
About Medical Properties Trust
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.